| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Revenue | $4.34B | -0.7% |
| Cost of Revenue | $1.47B | -2.5% |
| Gross Profit | $2.87B | +0.3% |
| R&D Expense | $967.0M | -17.3% |
| SG&A Expense | $1.09B | -0.5% |
| Operating Income | $807.0M | +196.9% |
| Pre-tax Income | $1.09B | +192.1% |
| Income Tax | $236.0M | +436.4% |
| Net Income | $850.0M |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Short-term Investments | $215.0M | +131.2% |
| Accounts Receivable | $854.0M | +16.2% |
| Inventory | $564.0M | +3.1% |
| Current Assets | $3.29B | +19.8% |
| Total Assets | $6.64B | +5.4% |
| Current Liabilities | $1.58B | +2.5% |
| Stockholders' Equity | $2.72B | +14.7% |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.08B | +28.9% |
| Capital Expenditures | $148.0M | +15.6% |
| Investing Cash Flow | -$55.0M | +69.1% |
| Financing Cash Flow | -$744.0M | -30.5% |
| Free Cash Flow | $931.0M | +31.3% |
| +169.5% |
| EPS (Basic) | $5.47 | +171.1% |
| EPS (Diluted) | $5.45 | +170.9% |